The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 70 results:
Author Title Type [ Year(Asc)]
Filters: Author is Cholongitas, Evangelos  [Clear All Filters]
2023
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
2018
Mastrokostas, A., Gavana M., Gkrizioti M., Smyrnakis E., Cholongitas E., Benos A., et al. (2018).  Discrepancies and misconceptions of perceived colorectal cancer screening barriers between primary health professionals and unscreened population. A comparative study in Greece.. J BUON. 23(7), 67-76.
Cholongitas, E., Haidich A-B., Apostolidou-Kiouti F., Chalevas P., & Papatheodoridis G. V. (2018).  Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.. Ann Gastroenterol. 31(4), 480-490.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome. World Journal of Gastroenterology. 24(12), 1285 - 1298.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome.. World J Gastroenterol. 24(12), 1285-1298.
Doumtsis, P., Oikonomou T., Goulis I., Zachou K., Dalekos G., & Cholongitas E. (2018).  Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia.. Ann Gastroenterol. 31(1), 123-126.
2017
Soulaidopoulos, S., Sinakos E., Dimopoulou D., Vettas C., Cholongitas E., & Garyfallos A. (2017).  Anticholinergic syndrome induced by toxic plants.. World J Emerg Med. 8(4), 297-301.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
2016
Makri, E., Cholongitas E., & Tziomalos K. (2016).  Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.. World J Gastroenterol. 22(41), 9039-9043.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
2015
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Cholongitas, E., Tziomalos K., & Pipili C. (2015).  Management of patients with hepatitis B in special populations.. World J Gastroenterol. 21(6), 1738-48.
2014
Cholongitas, E., Arsos G., Goulis J., Birtsou C., Haidich A-B., Nakouti T., et al. (2014).  Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis.. Hepatol Res. 44(10), E145-55.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
Theocharidou, E., Pieri G., Mohammad A. Omar, Cheung M., Cholongitas E., Agarwal B., et al. (2014).  The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score.. Am J Gastroenterol. 109(4), 554-62.
Cholongitas, E., Nakouti T., & Akriviadis E. (2014).  Tuberculous peritonitis after treatment for chronic hepatitis C.. Ann Gastroenterol. 27(4), 435-436.
2013
Cholongitas, E., Goulis J., Arsos G., Birtsou C., Nakouti T., Papadopoulou S., et al. (2013).  Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.. Clin Gastroenterol Hepatol. 11(7), 862-7.
2012
Cholongitas, E., Karatapanis S., Nakouti T., Birtsou C., Skorda L., Kouvelis I., et al. (2012).  Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?. Liver Int. 32(1), 172-3.
Cholongitas, E., Theocharidou E., Vasianopoulou P., Betrosian A., Shaw S., Patch D., et al. (2012).  Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.. Liver Transpl. 18(4), 405-12.
Cholongitas, E., Agarwal B., Antoniadis N., & Burroughs A. K. (2012).  Patients with cirrhosis admitted to an intensive care unit.. J Hepatol. 57(1), 230-1; author reply 231-2.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.